← Back to BEAM

Beam Therapeutics Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 04/08/2026Mar 2026Filed 04/08/2026Sep 2025Filed 04/11/2025Jun 2025Filed 04/08/2026Mar 2025Filed 04/08/2026Sep 2024Filed 04/11/2025Jun 2024Filed 04/11/2025Mar 2024Filed 04/11/2025
$0.5$32$9.7$8.5$7.5$14$12$7.4
−$123−$94−$113−$102−$108−$97−$91−$99
−$1.18−$0.91−$1.10−$1.00−$1.23−$1.17−$1.11−$1.21
10410310310288828282

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.